Recent Blog Posts

View Post: » Factor IX Deficiency in a 2-month Old
20 Nov 2009 by GeorgeFritsma  
His PTT was 53 seconds and his factor VIII was normal, but his factor IX was 4%. Looks like a pretty simple case of hemophilia B, however, after treatment with factor IX concentrates, his factor IX did not rise as expected. ...
View Blog: Untitled - http://www.fritsmafactor.com/newfritsmafactor/

---

View Post: Regulatory T Cells and Immune Tolerance to Coagulation Factor IX ...
24 Nov 2009 by Hengjun Chao  
Regulatory T Cells and Immune Tolerance to Coagulation Factor IX in the Context of Intramuscular AAV1 Gene Transfer. Molecular Therapy advance online publication, November 24, 2009. doi:10.1038/mt.2009.269 ...
View Blog: Molecular Therapy - AOP - nature.com science feeds - http://feeds.nature.com/mt/rss/aop

---

View Post: Scrip News - Biovitrum and Biogen Idec advance Factor IX product
21 Oct 2009
Biogen Idec and Biovitrum are to take their long-acting, fully-recombinant Factor IX Fc fusion protein (rFIXFc) into a pivotal clinical trial in haemophilia B patients. The decision was based on results from a Phase I/IIa open-label, ...
View Blog: Scrip News - Home - RSS - http://www.scripnews.com/home/

---

View Post: Title IX Blog: Is collegiate football dying?
15 hours ago by kris  
So Title IX was not a factor in the cuts. It was truly a money issue, primarily over the cost of renovating facilities that would attract quality players in order to become competitive again. But what I did notice was that with football ...
View Blog: Title IX Blog - http://title-ix.blogspot.com/

---

View Post: Hemophilia – A Bleeding Disorder In The Development of Sexual ...
22 Nov 2009 by expedient  
It is a genetic bleeding disorder where the blood clotting protein 'Factor IX' is missing or inadequate. This form of hemophilia is also known as Christmas disease or factor IX hemophilia. It is a less common form of hemophilia ...
View Blog: Health Watch Center - http://healthwatchcenter.blogspot.com/

---

View Post: Nastech To Develop Non-Injectable Dosage Form Of Factor IX To ...
1 Nov 2009 by admin  
%26quot;We look forward to working with our new global partner to evaluate the feasibility of delivering Factor IX without an injection,%26quot; stated Steven C. Quay, MD, Ph.D., Chairman, President and CEO of Nastech. ...
View Blog: Blair Blog - http://27000article.cn/blair/

---

View Post: Prophylactic Use of Factor IX Concentrate in a Jehovah's Witness ...
22 Oct 2009 by Bolliger, D., Sreeram, G., Duncan, A.,...  
For Jehovah's Witness patients who preoperatively give consent, factor IX concentrates may be acceptable for hemostatic therapy. We hereby describe a combination of "secondary components" to prevent excessive bleeding in a Jehovah's ...
View Blog: The Annals of Thoracic Surgery current issue - http://ats.ctsnetjournals.org/

---

View Post: BAC and Octapharma Extend Recombinant Factor IX Collaboration for ...
3 Nov 2009
BAC BV announced that it has entered into a licence agreement with Octapharma to use BAC's anti-Factor IX CaptureSelect® affinity ligand in the large scale purification of recombinant Factor IX (FIX). Octapharma produces FIX for the ...
View Blog: Bionity.COM News - http://www.bionity.com/news/e/

---

View Post: X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua).
23 Oct 2009 by Simioni P, Tormene D, Tognin G, Gavasso...  
We report a case of juvenile thrombophilia associated with a substitution of leucine for arginine at position 338 (R338L) in the factor IX gene (factor IX-R338L). The level of the mutant factor IX protein in plasma was normal, ...
View Blog: JournalFeeds - http://journalfeeds.com/

---